Although being adenocarcinoma was a favorable factor, cases with p16INK4-positive adenocarcinomas were significantly predictive of shorter survivals (RR: 2.0, 95% CI: 1.155–3.4623, P = 0.035) than the negative ones (Table 1). This evidence concerns the gene CDKN2A and adenocarcinoma.